bioAffinity Technologies, Inc. - Common Stock (NQ:BIAF)

3.411 -0.149 (-4.19%)

Delayed Quote Updated: 9:39 AM EDT, Oct 15, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about bioAffinity Technologies, Inc. - Common Stock

< Previous 1 2

...

7 8 9 10 11 12 13 14 Next >

bioAffinity Technologies Announces Pricing of $2.5 Million Registered Direct Offering and Concurrent Private Placement

March 06, 2024

From bioAffinity Technologies, Inc.

Via Business Wire

bioAffinity Technologies Reports Accelerating Sales Growth of CyPath® Lung

March 05, 2024

From bioAffinity Technologies, Inc.

Via Business Wire

Why SOPHiA GENETICS Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

March 05, 2024

Shares of SOPHiA GENETICS SA (NASDAQ: SOPH) fell sharply during Tuesday’s session after the company reported worse than expected fourth-quarter earnings and issued 2024 guidance.

Via Benzinga

bioAffinity Technologies News Update

February 21, 2024

From bioAffinity Technologies, Inc.

Via Business Wire

Medical Director of Lung Innovations Network and The Lung Center at Penn Highlands Healthcare, Sandeep Bansal, M.D., Joins bioAffinity Technologies’ Medical and Scientific Advisory Board and Incorporates CyPath® Lung into Medical Practice

February 06, 2024

From bioAffinity Technologies, Inc.

Via Business Wire

bioAffinity Technologies In The News

January 30, 2024

From bioAffinity Technologies, Inc.

Via Business Wire

bioAffinity Technologies Announces Award of Therapeutic Patent for Treatment of Cancer

January 23, 2024

From bioAffinity Technologies

Via Business Wire

bioAffinity Technologies In the News

January 08, 2024

From bioAffinity Technologies

Via Business Wire

bioAffinity Technologies and BioVie Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV

January 05, 2024

Via ACCESSWIRE

Why Compugen Shares Are Trading Higher By Over 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

December 19, 2023

Shares of Compugen Ltd. (NASDAQ: CGEN) shares rose sharply during Tuesday’s session after Gilead announced an agreement with the company to exclusively license its novel pre-clinical immunotherapy...

Via Benzinga

bioAffinity Technologies Appoints Jamie Platt, Ph.D., to its Board of Directors

December 05, 2023

From bioAffinity Technologies, Inc.

Via Business Wire

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

November 30, 2023

Via Benzinga

CMS Posts Final Payment Determination for bioAffinity Technologies’ CyPath® Lung Effective January 2024

November 30, 2023

From bioAffinity Technologies, Inc.

Via Business Wire

bioAffinity Technologies VP David Elzi, Ph.D., Named to American Society for Cell Biology Post

November 28, 2023

From bioAffinity Technologies, Inc.

Via Business Wire

bioAffinity Technologies Teams with American Cancer Society to Raise Funds for Lung Cancer Screening

November 15, 2023

From bioAffinity Technologies, Inc.

Via Business Wire

bioAffinity Technologies Reports Third Quarter 2023 Financial Results and Provides Business Update

November 14, 2023

From bioAffinity Technologies, Inc.

Via Business Wire

bioAffinity Technologies Names Dallas J. Coleman as National Director of Sales

November 06, 2023

From bioAffinity Technologies, Inc.

Via Business Wire

bioAffinity Technologies to Present at the 8th Annual Dawson James Small Cap Growth Conference

October 10, 2023

From bioAffinity Technologies, Inc.

Via Business Wire

Why Cal-Maine Foods Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

October 04, 2023

Gainers Gaucho Group Holdings, Inc. (NASDAQ: VINO) jumped 95.2% to $3.7280. Gaucho Group is planning to list two of its retail properties in Argentina, in San Rafael and Cordoba, for sale, priced at $2...

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

September 21, 2023

Via Benzinga

bioAffinity Technologies Acquires Laboratory Assets of Precision Pathology Services

September 19, 2023

From bioAffinity Technologies

Via Business Wire

bioAffinity Technologies to Participate in the H.C. Wainwright Global Investment Conference

September 07, 2023

From bioAffinity Technologies, Inc.

Via Business Wire

bioAffinity Technologies Reports Second Quarter 2023 Financial Results and Provides Business Update

August 14, 2023

From bioAffinity Technologies, Inc.

Via Business Wire

AMA Issues CPT Code for bioAffinity Technologies’ CyPath® Lung Test for Early-Stage Lung Cancer

July 12, 2023

From bioAffinity Technologies, Inc.

Via Business Wire

bioAffinity Technologies Presents Research Findings at UMass RNA Therapeutics Symposium

June 15, 2023

From bioAffinity Technologies, Inc.

Via Business Wire

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

June 12, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

June 06, 2023

Via Benzinga

bioAffinity Technologies Presents Research Findings at CYTO 2023

May 22, 2023

From bioAffinity Technologies, Inc.

Via Business Wire

bioAffinity Technologies Reports First Quarter 2023 Financial Results

May 15, 2023

From bioAffinity Technologies, Inc.

Via Business Wire

bioAffinity Technologies Names Michael Dougherty as Chief Financial Officer

May 01, 2023

From bioAffinity Technologies, Inc.

Via Business Wire

< Previous 1 2

...

7 8 9 10 11 12 13 14 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.